97 related articles for article (PubMed ID: 10652624)
1. Purification and characterization of a Hodgkin's and B cell-associated glycoprotein.
Wan KR; Wang MJ; Taylor CR; Imam SA
Anticancer Res; 1999; 19(4B):3275-81. PubMed ID: 10652624
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.
Imam SA; Taylor CR
Anticancer Res; 1996; 16(4A):1727-32. PubMed ID: 8712691
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
4. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
Imam A; Stathopoulos E; Taylor CR
Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
6. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
7. Protein expression pattern distinguishes different lymphoid neoplasms.
Fujii K; Kondo T; Yokoo H; Yamada T; Matsuno Y; Iwatsuki K; Hirohashi S
Proteomics; 2005 Nov; 5(16):4274-86. PubMed ID: 16206328
[TBL] [Abstract][Full Text] [Related]
8. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
9. Immunopurification, characterization, and nature of membrane association of human melanoma-associated oncofetal antigen gp87 defined by monoclonal antibody 140.240.
Liao SK; Kwong PC; Khosravi MJ
J Cell Biochem; 1985; 27(3):303-16. PubMed ID: 3886678
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40.
Braesch-Andersen S; Paulie S; Koho H; Nika H; Aspenström P; Perlmann P
J Immunol; 1989 Jan; 142(2):562-7. PubMed ID: 2463309
[TBL] [Abstract][Full Text] [Related]
11. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
Khnykin D; Troen G; Berner JM; Delabie J
J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
[TBL] [Abstract][Full Text] [Related]
12. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
[TBL] [Abstract][Full Text] [Related]
13. Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen.
Heaney-Kieras J; Bystryn JC
Cancer Res; 1982 Jun; 42(6):2310-6. PubMed ID: 7042082
[TBL] [Abstract][Full Text] [Related]
14. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.
Johnson VG; Schlom J; Paterson AJ; Bennett J; Magnani JL; Colcher D
Cancer Res; 1986 Feb; 46(2):850-7. PubMed ID: 3940648
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and structural properties of a Hodgkin's disease-related membrane protein.
Nawrocki JF; Kirsten ES; Fisher RI
J Immunol; 1988 Jul; 141(2):672-80. PubMed ID: 3385212
[TBL] [Abstract][Full Text] [Related]
16. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
17. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
18. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the human adenocarcinoma-associated glycoprotein gp40.
Sportsman JR; Taber LD; Slisz MC; Apelgren LD; Bumol TF
Biotechnol Appl Biochem; 1988 Dec; 10(6):536-44. PubMed ID: 3069116
[TBL] [Abstract][Full Text] [Related]
20. Purification and partial characterization of a preneoplastic antigen in liver carcinogenesis.
Lin JC; Kligman L; Farber E
Cancer Res; 1980 Oct; 40(10):3755-62. PubMed ID: 7438059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
